MétaCan
Menu
Back to cohort
Record W3087587973 · doi:10.1111/add.15254

Challenging CBD protective effect against THC‐related outcomes: a call for robust clinical trials

2020· article· en· W3087587973 on OpenAlexaffabout
Violaine Mongeau‐Pérusse, Didier Jutras‐Aswad

Bibliographic record

VenueAddiction · 2020
Typearticle
Languageen
FieldMedicine
TopicCannabis and Cannabinoid Research
Canadian institutionsUniversité de MontréalCentre Hospitalier de l’Université de Montréal
Fundersnot available
KeywordsCannabidiolCannabisTetrahydrocannabinolMedicineDronabinolDoseAdverse effectPharmacologyPsychiatryCannabinoidInternal medicine

Abstract

fetched live from OpenAlex

Cannabis is consumed by more than 182 million people worldwide [1] and research on cannabinoids is booming, with the potential of supporting public health initiatives that promote safer cannabis use. It has been proposed that cannabidiol (CBD) can guard against adverse effects of tetrahydrocannabinol (THC), which has led governmental and academic bodies to recommend the use of cannabis products with high CBD : THC ratios (e.g. [2]). We believe that the evidence for this is weak. Observational studies have demonstrated a possible protective effect of CBD on memory and psychotic symptoms [3-5]. However, this type of study has a high risk of selection bias and limited capacity to distinguish between the various doses and ratios of THC and CBD contained in cannabis. Experimental studies supporting the protective effect of CBD have typically used dosages that are not found in real-world contexts [6]. To reflect such conditions, studies should use cannabis products containing CBD levels found in the recreational market (e.g. below 100 mg), not only assessing oral, but also smoked and vaporized administration methods. Well-designed randomized trials have actually yielded a mixed and complex pattern of results [6]. For example, when compared to THC alone, vaporized THC combined with high-dose CBD (400 mg) reduced intoxication, while low-dose CBD (4 mg) enhanced intoxication [7]. Although vaporized CBD may attenuate THC impairment on emotional affect recognition [8], it has not been clearly found to mitigate psychotic symptoms and memory impairment [9]. Equivalent doses of vaporized CBD and THC may worsen attention and working memory compared with THC alone [10]. Despite conflicting evidence, users are currently encouraged to favour products containing CBD which, if most probably not harmful, may not provide the protective effects advertised thus far. Consequently, there is an urgent need for well-designed clinical trials in ecologically valid conditions. These conditions include naturalistic dosage corresponding to recreational market products. InSYS therapeutics provided cannabidiol to D.J.-A's team for a clinical trial funded by the Canadian Institute of Health Research. The Quebec government funded D.J.-A.'s work, but had no role in writing or deciding to publish this letter. Violaine Mongeau-Pérusse: Conceptualization; formal analysis; methodology. Didier Jutras-Aswad: Conceptualization; formal analysis; methodology; supervision.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.008
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.724
Threshold uncertainty score0.962

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.008
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.118
GPT teacher head0.418
Teacher spread0.300 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueAddictionSame topicCannabis and Cannabinoid ResearchFrench-language works237,207